DRG 319
Surgical DRGOther Endovascular Cardiac Valve Procedures with MCC
What is MS-DRG 319?
MS-DRG 319 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) with a Major Complication or Comorbidity (MCC). For FY 2026 it carries a relative weight of 4.4629 with a geometric mean length of stay of 7.4 days and an arithmetic mean of 10.2 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
FY 2026 Payment Data
Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).
Related MS-DRGs in This Severity Group
The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.
| DRG | Title | Rel. Weight | GMLOS |
|---|---|---|---|
| 319 | Other Endovascular Cardiac Valve Procedures with MCCThis page | 4.4629 | 7.4 days |
| 320 | Other Endovascular Cardiac Valve Procedures without MCC | 2.4053 | 2.1 days |
Linked ICD-10-PCS Procedure Mappings
- 025F3ZZ
Destruction of Aortic Valve, Percutaneous Approach
BillableSection 0 - 025G3ZZ
Destruction of Mitral Valve, Percutaneous Approach
BillableSection 0 - 025H3ZZ
Destruction of Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 025J3ZZ
Destruction of Tricuspid Valve, Percutaneous Approach
BillableSection 0 - 027F0ZZ
Dilation of Aortic Valve, Open Approach
BillableSection 0 - 027G0ZZ
Dilation of Mitral Valve, Open Approach
BillableSection 0 - 027H0ZZ
Dilation of Pulmonary Valve, Open Approach
BillableSection 0 - 027J0ZZ
Dilation of Tricuspid Valve, Open Approach
BillableSection 0 - 02BF3ZZ
Excision of Aortic Valve, Percutaneous Approach
BillableSection 0 - 02BG3ZZ
Excision of Mitral Valve, Percutaneous Approach
BillableSection 0 - 02BH3ZZ
Excision of Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02BJ3ZZ
Excision of Tricuspid Valve, Percutaneous Approach
BillableSection 0 - 02QF3ZJ
Repair Aortic Valve created from Truncal Valve, Percutaneous Approach
BillableSection 0 - 02QF3ZZ
Repair Aortic Valve, Percutaneous Approach
BillableSection 0 - 02QG3ZE
Repair Mitral Valve created from Left Atrioventricular Valve, Percutaneous Approach
BillableSection 0 - 02QG3ZZ
Repair Mitral Valve, Percutaneous Approach
BillableSection 0 - 02QH3ZZ
Repair Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02QJ3ZG
Repair Tricuspid Valve created from Right Atrioventricular Valve, Percutaneous Approach
BillableSection 0 - 02QJ3ZZ
Repair Tricuspid Valve, Percutaneous Approach
BillableSection 0 - 02TH3ZZ
Resection of Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02VG3ZZ
Restriction of Mitral Valve, Percutaneous Approach
BillableSection 0 - 02WF38Z
Revision of Zooplastic Tissue in Aortic Valve, Percutaneous Approach
BillableSection 0 - 02WF3JZ
Revision of Synthetic Substitute in Aortic Valve, Percutaneous Approach
BillableSection 0 - 02WF3KZ
Revision of Nonautologous Tissue Substitute in Aortic Valve, Percutaneous Approach
BillableSection 0 - 02WG37Z
Revision of Autologous Tissue Substitute in Mitral Valve, Percutaneous Approach
BillableSection 0 - 02WG38Z
Revision of Zooplastic Tissue in Mitral Valve, Percutaneous Approach
BillableSection 0 - 02WG3JZ
Revision of Synthetic Substitute in Mitral Valve, Percutaneous Approach
BillableSection 0 - 02WG3KZ
Revision of Nonautologous Tissue Substitute in Mitral Valve, Percutaneous Approach
BillableSection 0 - 02WH37Z
Revision of Autologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02WH38Z
Revision of Zooplastic Tissue in Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02WH3JZ
Revision of Synthetic Substitute in Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02WH3KZ
Revision of Nonautologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach
BillableSection 0 - 02WJ37Z
Revision of Autologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach
BillableSection 0 - 02WJ38Z
Revision of Zooplastic Tissue in Tricuspid Valve, Percutaneous Approach
BillableSection 0 - 02WJ3JZ
Revision of Synthetic Substitute in Tricuspid Valve, Percutaneous Approach
BillableSection 0 - 02WJ3KZ
Revision of Nonautologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach
BillableSection 0 - X28F3VA
Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10
BillableSection X - X28F3WB
Division of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11
BillableSection X
